[PDF][PDF] Targeted therapies for epithelial cancers: in vivo efficacy of the BCL-2/BCL-XL inhibitor 2-MeAA
PS Schwartz, DM Hockenbery - Cancer Biology & Therapy, 2007 - Taylor & Francis
PS Schwartz, DM Hockenbery
Cancer Biology & Therapy, 2007•Taylor & FrancisCommentary to: Bcl2/bcl-xl Inhibitor Engenders Apoptosis and Increases Chemo-sensitivity
In Mesothelioma Xiaobo Cao, Charles Rodarts, Lidong Zhang, Clinton D. Morgan, James
Littlejohn and W. Roy Smythe Cancer Biology & Therapy Volume: 6| Issue: 2| Pages: 246-
252
In Mesothelioma Xiaobo Cao, Charles Rodarts, Lidong Zhang, Clinton D. Morgan, James
Littlejohn and W. Roy Smythe Cancer Biology & Therapy Volume: 6| Issue: 2| Pages: 246-
252
Commentary to:
Bcl2/bcl-xl Inhibitor Engenders Apoptosis and Increases Chemo-sensitivity In Mesothelioma
Xiaobo Cao, Charles Rodarts, Lidong Zhang, Clinton D. Morgan, James Littlejohn and W. Roy Smythe
Cancer Biology & Therapy Volume: 6 | Issue: 2 | Pages: 246 - 252
Taylor & Francis Online
以上显示的是最相近的搜索结果。 查看全部搜索结果